ClinicalTrials.Veeva

Menu

How Cricket Powder Affects Gut Microbiome and Cholesterol Metabolism (CricketOnME)

M

Mahidol University

Status

Completed

Conditions

Hypercholesterolemia

Treatments

Other: Placebo
Dietary Supplement: Cricket Powder

Study type

Interventional

Funder types

Other

Identifiers

NCT07009756
MU-MOU 2023-334.2710 (Other Identifier)

Details and patient eligibility

About

Cardiovascular disease (CVD) is the leading cause of death worldwide, including in Thailand. One of the major risk factors for CVD is dyslipidemia, or abnormal levels of cholesterol and other fats in the blood. Recent research suggests that the balance of gut microbiota, the community of microorganisms living in the digestive system, may play a key role in regulating cholesterol levels and overall metabolism.

This study explored the potential health benefits of cricket powder, a high-protein food that is already safely consumed in many parts of the world. Previous studies have shown that cricket powder may increase the number of beneficial gut bacteria, especially Bifidobacterium animalis, which supports the production of short-chain fatty acids (SCFAs) known to improve fat metabolism.

Although crickets are considered safe to eat, more research is needed to understand their effects on gut health and blood cholesterol, especially in people with high cholesterol levels. This study assessed the safety of cricket powder consumption and whether it can help improve gut microbiota balance and lower cholesterol in Thai adults.

Enrollment

17 patients

Sex

All

Ages

20 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy, aged in the 20 - 60 range
  • BMI (Body Mass Index) in the range of 18.5 - 29.9 kg/m2
  • No underlying diseases
  • No gastrointestinal surgery
  • The fasting blood parameters of total cholesterol and LDL-C are higher than 200 mg/dL and 130 - 189 mg/dL, respectively.
  • The fasting blood triglyceride must be less than 500 mg/dL.
  • The fasting blood glucose must be less than 110 mg/dL.
  • ALT (Alanine aminotransferase) and AST (Aspartate aminotransferase) must be less than 60 units/L.
  • eGFR (estimated glomerular filtration rate) must be at least 90 mL/min/1.73 m2.
  • Blood pressure must be less than 160/90 mmHg.
  • Heart rate must be less than 100 times/minute.
  • No smoking
  • Be able to consume pork congee

Exclusion criteria

  • Allergic to insects, chitin, chitosan, shrimp, dust mites, and other crustacean products
  • Pregnant or breastfeeding
  • Participating in other research projects, and receiving drugs, herbs, and supplements
  • Receiving steroid, antibiotic, or other drugs that may affect lipid metabolism
  • Consuming alcohol more than 2 drinks per day e.g., beer of 24 ounces, wine of 10 ounces, and distilled spirits of 3 ounces
  • Regularly consuming probiotic products and cannot stop consuming them
  • Having histories of diabetes, chronic liver diseases, chronic kidney diseases, cardiovascular diseases, cancer, anemia, irritable bowel syndrome, ulcerative colitis, or anaphylaxis

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

17 participants in 2 patient groups

Cricket Powder First, Then Placebo
Experimental group
Description:
Participants in this arm will consume a daily serving of cricket powder congee for 21 consecutive days, followed by a 28-day washout period, and then consume a daily serving of placebo congee (pork congee) for another 21 consecutive days.
Treatment:
Dietary Supplement: Cricket Powder
Other: Placebo
Placebo First, Then Cricket Powder
Experimental group
Description:
Participants in this arm will consume a daily serving of placebo congee (pork congee) for 21 consecutive days, followed by a 28-day washout period, and then consume a daily serving of cricket powder congee for another 21 consecutive days.
Treatment:
Dietary Supplement: Cricket Powder
Other: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems